New Covid-19 treatments for highest risk Covid patients (non-hospitalised patients)
New treatments for patients at highest risk of severe disease from Covid 19 infection are available for non-hospitalised patients from Thursday 16 December.
The treatments include Neutralising monoclonal antibodies (nMABs) given by injection, or antiviral tablets which are swallowed. These treatments being given to patients at a dedicated clinic, known as the Covid Medical Delivery Unit. GP practices cannot prescribe these treatments and they are only licenced for patients with the highest risk with COVID-19. People who can benefit from these treatments will receive a letter or email telling them in advance that they may be eligible for these treatments if they test PCR positive for Covid-19. They also may be contacted by their specialist consultant. Information about the treatments can be found on the NHS website: https://www.nhs.uk/conditions/coronavirus-covid-19/treatments-for-coronavirus/
Covid antiviral trials
If you have tested positive for Covid-19 and would like to take part in trials using antiviral treatments the surgery recommends you to self-refer to the PANORAMIC study where the study organisers will assess your eligibility.
The NHS is awaiting national guidance that lets us extend the availability of COVID-19 booster jabs to all adults, a minimum of three months after receiving their second jabs. Thank you for your patience while we put this in place. For the time being, please only come for your booster jab if you are over the age of 40, and it has been more than six months since you had your second jab. If this does not apply to you, then an announcement will be made when you can get your booster. - 02/12/2021
COVID Vaccinations Abroad
Please see the following guidance: Using your NHS COVID Pass for travel abroad and at venues and settings in England - GOV.UK (www.gov.uk)
You can book an appointment via this link: Tell the NHS about coronavirus (COVID-19) vaccinations you've had abroad - NHS (www.nhs.uk)